xCures Closes $46 Million Series B Financing to Transform Fragmented Medical Records into Decision-ready Data through its Clinical Clarity Engine
New capital brings total funding to more than $76 million and will fuel continued expansion of the company's platform for...
Hemostemix to Highlight Commercial Phase I Longevity Treatment at Small Cap Growth Investor Conference